Bone marrow transplantation in multiple myeloma

S. Tura, M. Cavo, M. Baccarani, P. Ricci, M. Gobbi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We report 3 cases of allogeneic bone marrow transplantation in multiple myeloma that we have recently performed. Following conditioning treatment with i.v. cyclophosphamide (60 mg/kg/d, for 2 d), oral melphalan (1.0 mg/kg/d, for 5 d), i.v. BCNU (5.5 mg/kg, in a single dose) and total body irradiation (10 Gy in a single fraction) we observed in all 3 cases the disappearance both of serum M component and of monoclonal bone marrow plasma cells. 1 patient died of actue GVH disease, grade IV, at 2 months, while the other 2 patients are in good health and in unmaintained complete remission at 4 and 20 months, respectively. The usefulness of allogeneic bone marrow transplantation in the management of multiple myeloma is emphasized.

Original languageEnglish
Pages (from-to)176-179
Number of pages4
JournalScandinavian Journal of Haematology
Volume36
Issue number2
Publication statusPublished - 1986

Fingerprint

Homologous Transplantation
Multiple Myeloma
Bone Marrow Transplantation
Myeloma Proteins
Carmustine
Melphalan
Whole-Body Irradiation
Plasma Cells
Bone Marrow Cells
Cyclophosphamide
Health
Serum
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Tura, S., Cavo, M., Baccarani, M., Ricci, P., & Gobbi, M. (1986). Bone marrow transplantation in multiple myeloma. Scandinavian Journal of Haematology, 36(2), 176-179.

Bone marrow transplantation in multiple myeloma. / Tura, S.; Cavo, M.; Baccarani, M.; Ricci, P.; Gobbi, M.

In: Scandinavian Journal of Haematology, Vol. 36, No. 2, 1986, p. 176-179.

Research output: Contribution to journalArticle

Tura, S, Cavo, M, Baccarani, M, Ricci, P & Gobbi, M 1986, 'Bone marrow transplantation in multiple myeloma', Scandinavian Journal of Haematology, vol. 36, no. 2, pp. 176-179.
Tura S, Cavo M, Baccarani M, Ricci P, Gobbi M. Bone marrow transplantation in multiple myeloma. Scandinavian Journal of Haematology. 1986;36(2):176-179.
Tura, S. ; Cavo, M. ; Baccarani, M. ; Ricci, P. ; Gobbi, M. / Bone marrow transplantation in multiple myeloma. In: Scandinavian Journal of Haematology. 1986 ; Vol. 36, No. 2. pp. 176-179.
@article{b6dc93eaa59142adbb9cc38192c3484b,
title = "Bone marrow transplantation in multiple myeloma",
abstract = "We report 3 cases of allogeneic bone marrow transplantation in multiple myeloma that we have recently performed. Following conditioning treatment with i.v. cyclophosphamide (60 mg/kg/d, for 2 d), oral melphalan (1.0 mg/kg/d, for 5 d), i.v. BCNU (5.5 mg/kg, in a single dose) and total body irradiation (10 Gy in a single fraction) we observed in all 3 cases the disappearance both of serum M component and of monoclonal bone marrow plasma cells. 1 patient died of actue GVH disease, grade IV, at 2 months, while the other 2 patients are in good health and in unmaintained complete remission at 4 and 20 months, respectively. The usefulness of allogeneic bone marrow transplantation in the management of multiple myeloma is emphasized.",
author = "S. Tura and M. Cavo and M. Baccarani and P. Ricci and M. Gobbi",
year = "1986",
language = "English",
volume = "36",
pages = "176--179",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Bone marrow transplantation in multiple myeloma

AU - Tura, S.

AU - Cavo, M.

AU - Baccarani, M.

AU - Ricci, P.

AU - Gobbi, M.

PY - 1986

Y1 - 1986

N2 - We report 3 cases of allogeneic bone marrow transplantation in multiple myeloma that we have recently performed. Following conditioning treatment with i.v. cyclophosphamide (60 mg/kg/d, for 2 d), oral melphalan (1.0 mg/kg/d, for 5 d), i.v. BCNU (5.5 mg/kg, in a single dose) and total body irradiation (10 Gy in a single fraction) we observed in all 3 cases the disappearance both of serum M component and of monoclonal bone marrow plasma cells. 1 patient died of actue GVH disease, grade IV, at 2 months, while the other 2 patients are in good health and in unmaintained complete remission at 4 and 20 months, respectively. The usefulness of allogeneic bone marrow transplantation in the management of multiple myeloma is emphasized.

AB - We report 3 cases of allogeneic bone marrow transplantation in multiple myeloma that we have recently performed. Following conditioning treatment with i.v. cyclophosphamide (60 mg/kg/d, for 2 d), oral melphalan (1.0 mg/kg/d, for 5 d), i.v. BCNU (5.5 mg/kg, in a single dose) and total body irradiation (10 Gy in a single fraction) we observed in all 3 cases the disappearance both of serum M component and of monoclonal bone marrow plasma cells. 1 patient died of actue GVH disease, grade IV, at 2 months, while the other 2 patients are in good health and in unmaintained complete remission at 4 and 20 months, respectively. The usefulness of allogeneic bone marrow transplantation in the management of multiple myeloma is emphasized.

UR - http://www.scopus.com/inward/record.url?scp=0022608809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022608809&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 176

EP - 179

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 2

ER -